Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Chunpu Li; Gang Cai; Daqian Song; Ruixuan Gao; Peng Teng; LiHong Zhou; Qing Ji; Hua Sui; Jianfeng Cai; Qi Li; Yan Wang

doi:10.1039/D4BM90079K

Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Chunpu Li,^ab Gang Cai,^a Daqian Song,^a Ruixuan Gao,^b Peng Teng,^b LiHong Zhou,^a Qing Ji,^a Hua Sui,^a Jianfeng Cai,*^b Qi Li*^a and Yan Wang*^a

Author affiliations

* Corresponding authors

^a Department of Medical Oncology & Cancer institute of medicine, Shuguang Hospital, Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
E-mail: lzwf@hotmail.com, wangyan_sg@126.com

^b Department of Chemistry, University of South Florida, 4202 E. Fowler Ave, Tampa, FL 33620, USA
E-mail: jianfengcai@usf.edu

Abstract

Retraction of ‘Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer’ by Chunpu Li et al., Biomater. Sci., 2019, 7, 3627–3639, https://doi.org/10.1039/C9BM00613C.

Biomaterials Science

Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Abstract

Associated articles

Article information

Download Citation

Permissions

Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Social activity

Search articles by author

Spotlight

Advertisements